Aztrazeneca
- All
- News
- Videos
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
- Monday May 20, 2024
- World News | Agence France-Presse
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
- Friday May 7, 2021
- World News | Agence France-Presse
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
- www.ndtv.com
-
Germany To Recommend Oxford Covid Vaccine For Over 65s: Angela Merkel
- Thursday March 4, 2021
- World News | Agence France-Presse
Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.
- www.ndtv.com
-
AstraZeneca Gets US Approval for Gout Drug
- Wednesday December 23, 2015
- Business | Thomson Reuters
US health regulators on Tuesday approved AztraZeneca's drug Zurampic to treat a condition associated with gout to be used in combination with another type of drug that reduces production of uric acid in the body.
- www.ndtv.com/business
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
- Monday May 20, 2024
- World News | Agence France-Presse
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | Reported by Vishnu Som
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
- Wednesday May 8, 2024
- India News | NDTV News Desk
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
- www.ndtv.com
-
UK Advises Under-40s Get Alternative To AstraZeneca Covid Vaccine
- Friday May 7, 2021
- World News | Agence France-Presse
The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.
- www.ndtv.com
-
Germany To Recommend Oxford Covid Vaccine For Over 65s: Angela Merkel
- Thursday March 4, 2021
- World News | Agence France-Presse
Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.
- www.ndtv.com
-
AstraZeneca Gets US Approval for Gout Drug
- Wednesday December 23, 2015
- Business | Thomson Reuters
US health regulators on Tuesday approved AztraZeneca's drug Zurampic to treat a condition associated with gout to be used in combination with another type of drug that reduces production of uric acid in the body.
- www.ndtv.com/business